BiotechTube

FLOSEAL Hemostatic Matrix + Standard of care

ApprovedCompleted
0 views this week 0 watching⚡ Active
Interest: 40/100
40
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Knee Replacement Surgery

Conditions

Knee Replacement Surgery, Osteoarthritis

Trial Timeline

Sep 1, 2011 → Jan 1, 2013

NCT ID
NCT01410240

About FLOSEAL Hemostatic Matrix + Standard of care

FLOSEAL Hemostatic Matrix + Standard of care is a approved stage product being developed by Baxter for Knee Replacement Surgery. The current trial status is completed. This product is registered under clinical trial identifier NCT01410240. Target conditions include Knee Replacement Surgery, Osteoarthritis.

What happened to similar drugs?

10 of 20 similar drugs in Knee Replacement Surgery were approved

Approved (10) Terminated (0) Active (10)
✅NISEDr. Reddy's LaboratoriesApproved
✅Capsaicin Topical SolutionAstellas PharmaApproved
✅ImrecoxibJiangsu Hengrui MedicineApproved
✅celecoxibPfizerApproved
✅Ibuprofen + Placebo + CelecoxibPfizerApproved
✅Celecoxib + Naproxen + PlaceboPfizerApproved
✅Celecoxib + PlaceboPfizerApproved

Hype Score Breakdown

Clinical
20
Activity
8
Company
12
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT01410240ApprovedCompleted

Competing Products

20 competing products in Knee Replacement Surgery

See all competitors
ProductCompanyStageHype Score
NISEDr. Reddy's LaboratoriesApproved
40
NISELATDr. Reddy's LaboratoriesPre-clinical
23
LY2828360 + PlaceboEli LillyPhase 2
35
UBX0101 or placeboUnity BiotechnologyPre-clinical
8
UBX0101Unity BiotechnologyPhase 1
19
UBX0101Unity BiotechnologyPhase 2
25
UBX0101Unity BiotechnologyPhase 1
19
YH23537 + Celecoxib + YH23537 placeboYuhanPhase 2
35
YM150 + WarfarinAstellas PharmaPhase 2
35
ASP7962 + Naproxen + PlaceboAstellas PharmaPhase 2
35
Capsaicin Topical SolutionAstellas PharmaApproved
43
CGS-200-1 + CGS-200-5 + CGS-200 VehicleAstellas PharmaPhase 2
35
MM-II dose I + MM-II dose II + MM-II dose III + Placebo + Placebo + PlaceboSun PharmaceuticalPhase 2
35
Duloxetine + PlaceboShionogiPhase 3
40
DuloxetineShionogiPhase 3
40
V120083 + Naproxen + PlaceboShionogiPhase 2
35
ONO-4474 + Placebo matching ONO-4474Ono PharmaceuticalPhase 2
27
Duloxetine + PlaceboEli LillyPhase 3
40
Duloxetine (DLX) + Placebo (PLA)Eli LillyPhase 3
40
Duloxetine + placeboEli LillyPhase 3
40